Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
AKT serine/threonine kinase 3 | 0.512 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
AKT serine/threonine kinase 3 | 0.512 | 0.808 | 1.00 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
AKT serine/threonine kinase 3 | 0.512 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 1 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
disease | 0.100 | None | 0 | 2 | ||||||||||||
|
nuclear receptor subfamily 2 group E member 3 | 0.603 | 0.500 |
|
phenotype | 0.100 | None | 0 | 1 | ||||||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
group | 0.100 | None | 0 | 1 | ||||||||||||
|
ghrelin opposite strand/antisense RNA | 1.000 | 0.077 |
|
disease | 0.100 | None | 0 | 2 | ||||||||||||
|
ghrelin opposite strand/antisense RNA | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 0 | 2 | ||||||||||||
|
ghrelin opposite strand/antisense RNA | 1.000 | 0.077 |
|
phenotype | 0.100 | None | 0 | 1 | ||||||||||||
|
PLCE1 antisense RNA 1 | 1.000 | 0.077 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
myosin heavy chain gene cluster antisense RNA | 0.890 | 0.269 |
|
group | 0.100 | None | 0 | 1 | ||||||||||||
|
myosin heavy chain gene cluster antisense RNA | 0.890 | 0.269 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
myosin heavy chain gene cluster antisense RNA | 0.890 | 0.269 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
zinc finger and BTB domain containing 42 | 0.931 | 0.115 | 0.34 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
DDC antisense RNA 1 | 1.000 |
|
disease | 0.100 | None | 0 | 2 | |||||||||||||
|
MKRN2 opposite strand | 0.931 | 0.077 | 3.8E-05 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||
|
MKRN2 opposite strand | 0.931 | 0.077 | 3.8E-05 |
|
disease | 0.100 | None | 0 | 5 | |||||||||||
|
inhibitor of carbonic anhydrase pseudogene | 0.890 | 0.231 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
urate (hydroxyiso-) hydrolase, pseudogene | 1.000 |
|
disease | 0.100 | None | 0 | 1 | |||||||||||||
|
TFAP2A antisense RNA 1 | 0.890 | 0.115 |
|
disease | 0.100 | None | 0 | 1 | ||||||||||||
|
chromosome 17 open reading frame 107 | 0.821 | 0.115 | 6.9E-02 |
|
disease | 0.100 | None | 0 | 17 |